Literature DB >> 9494837

Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome.

B M Allos1.   

Abstract

A previously unrecognized sequelum of infection with Campylobacter jejuni, a common cause of gastroenteritis, is Guillain-Barré syndrome (GBS). GBS is the most common cause of acute neuromuscular paralysis; 30% to 40% of cases are preceded by C. jejuni infection. Both patient and bacterial characteristics likely play a role in the pathogenesis of C. jejuni-induced GBS. Molecular mimicry between the LPS of some campylobacters and structures present on the gangliosides of the peripheral nerve may explain how this acute infectious diarrheal illness triggers GBS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494837     DOI: 10.1016/s0891-5520(05)70416-5

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  9 in total

1.  Detection of heat-stable antigens of Campylobacter jejuni and C. coli by direct agglutination and passive hemagglutination.

Authors:  A N Oza; R T Thwaites; D R A Wareing; F J Bolton; J A Frost
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Characterization of Campylobacter jejuni RacRS reveals roles in the heat shock response, motility, and maintenance of cell length homogeneity.

Authors:  Dmitry Apel; Jeremy Ellermeier; Mark Pryjma; Victor J Dirita; Erin C Gaynor
Journal:  J Bacteriol       Date:  2012-02-17       Impact factor: 3.490

3.  Genome Dynamics and Molecular Infection Epidemiology of Multidrug-Resistant Helicobacter pullorum Isolates Obtained from Broiler and Free-Range Chickens in India.

Authors:  Shamsul Qumar; Mohammad Majid; Narender Kumar; Sumeet K Tiwari; Torsten Semmler; Savita Devi; Ramani Baddam; Arif Hussain; Sabiha Shaik; Niyaz Ahmed
Journal:  Appl Environ Microbiol       Date:  2016-12-15       Impact factor: 4.792

4.  Rapid identification of thermotolerant Campylobacter jejuni, Campylobacter coli, Campylobacter lari, and Campylobacter upsaliensis from various geographic locations by a GTPase-based PCR-reverse hybridization assay.

Authors:  L J van Doorn; A Verschuuren-van Haperen; A Burnens; M Huysmans; P Vandamme; B A Giesendorf; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.

Authors:  Mohammed A El-Bayoumi; Ahmed M El-Refaey; Alaa M Abdelkader; Mohamed M A El-Assmy; Angi A Alwakeel; Hanem M El-Tahan
Journal:  Crit Care       Date:  2011-07-11       Impact factor: 9.097

6.  Guillain-Barré syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: A case report.

Authors:  Zauraiz Anjum; Charoo Iyer; Sidra Naz; Vikash Jaiswal; Gaurav Nepal; Maryrose Laguio-Vila; Sanjay Anandaram; Sahil Thapaliya
Journal:  Clin Case Rep       Date:  2022-04-14

7.  Campylobacter jejuni strains from patients with Guillain-Barré syndrome.

Authors:  B M Allos; F T Lippy; A Carlsen; R G Washburn; M J Blaser
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

8.  Campylobacter infection as a trigger for Guillain-Barré syndrome in Egypt.

Authors:  Thomas F Wierzba; Ibrahim Adib Abdel-Messih; Bayoumi Gharib; Shahida Baqar; Amina Hendaui; Ibrahim Khalil; Tarek A Omar; Hamed E Khayat; Shannon D Putnam; John W Sanders; Lai-King Ng; Lawrence J Price; Daniel A Scott; Robert R Frenck
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

Review 9.  Neurological Manifestations of Dengue Infection.

Authors:  Guo-Hong Li; Zhi-Jie Ning; Yi-Ming Liu; Xiao-Hong Li
Journal:  Front Cell Infect Microbiol       Date:  2017-10-25       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.